-
EP1745779
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1745779
| EP1745779 - Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.01.2014 Database last updated on 02.11.2024 | Most recent event Tooltip | 03.01.2014 | Application deemed to be withdrawn | published on 05.02.2014 [2014/06] | Applicant(s) | For all designated states CXR Biosciences Limited Dundee Technopole, James Lindsay Place Dundee DD1 5JJ / GB | [N/P] |
| Former [2007/04] | For all designated states CXR BIOSCIENCES LIMITED Dundee Technopole, James Lindsay Place Dundee DD1 5JJ / GB | Inventor(s) | 01 /
Elcombe, Clifford Roy CXR Biosciences Limited James Lindsay Place Dundee DD1 5JJ / GB | 02 /
Wolf, Charles Roland CXR Biosciences Limited James Lindsay Place Dundee DD1 5JJ / GB | [2007/04] | Representative(s) | Potter Clarkson Chapel Quarter Mount Street Nottingham NG1 6HQ / GB | [N/P] |
| Former [2013/37] | Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | ||
| Former [2010/02] | Wainwright, Jane Helen, et al Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
| Former [2007/04] | Pilkington, Stephanie Joan, et al Eric Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 06076555.9 | 18.02.2002 | [2007/04] | Priority number, date | GB20010003809 | 16.02.2001 Original published format: GB 0103809 | [2007/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1745779 | Date: | 24.01.2007 | Language: | EN | [2007/04] | Type: | A3 Search report | No.: | EP1745779 | Date: | 04.05.2011 | [2011/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.04.2011 | Classification | IPC: | A61K31/19, A61K31/20, A61P3/06, A61P3/10, A61P19/02, A61P29/00, A61P35/00 | [2010/29] | CPC: |
G01N33/92 (EP,US);
A61K31/19 (EP,US);
A61K31/20 (EP,US);
A61P11/00 (EP);
A61P11/16 (EP);
A61P15/00 (EP);
A61P19/02 (EP);
A61P29/00 (EP);
A61P3/00 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/08 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
|
| Former IPC [2007/04] | A61K31/19, A61K31/20, G01N33/92 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2007/04] | Title | German: | Verwendung perfluorierter Carbonsäurederivate zur Herstellung eines Medikaments zur Modulierung der Körpermasse | [2007/04] | English: | Uses of perfluorinated carboylic acid derivatives for the manufacture of a medicament for the modulation of body mass | [2007/04] | French: | Utilisation de dérivés d'acides carboxyliques perfluorinés pour la fabrication d'un medicament pour la modulation de la masse corporelle | [2007/04] | Examination procedure | 31.08.2006 | Examination requested [2007/04] | 31.10.2011 | Amendment by applicant (claims and/or description) | 03.09.2013 | Application deemed to be withdrawn, date of legal effect [2014/06] | 27.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/06] | Parent application(s) Tooltip | EP02712094.8 / EP1359906 | Divisional application(s) | EP10075491.0 / EP2260842 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20020712094) is 19.10.2004 | Fees paid | Renewal fee | 31.08.2006 | Renewal fee patent year 03 | 31.08.2006 | Renewal fee patent year 04 | 31.08.2006 | Renewal fee patent year 05 | 26.04.2007 | Renewal fee patent year 06 | 13.02.2008 | Renewal fee patent year 07 | 26.02.2009 | Renewal fee patent year 08 | 26.02.2010 | Renewal fee patent year 09 | 25.02.2011 | Renewal fee patent year 10 | 28.02.2012 | Renewal fee patent year 11 | Penalty fee | Additional fee for renewal fee | 28.02.2007 | 06 M06 Fee paid on 26.04.2007 | 28.02.2013 | 12 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - KEES, K. L. ET AL., "Perfluorcarbon-based antidiabetic agents", JOURNAL OF MEDICINAL CHEMISTRY, (1992), vol. 35, pages 944 - 953, XP001077054 [X] 1,5,6,8-11 * abstract; page 950, column 2, paragraph L * DOI: http://dx.doi.org/10.1021/jm00083a021 | [X] - BORGES, T. ET AL., "Effect of peroxisome proliferator perfluorooctanoic acid on growth of lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium", ARCHIVES OF TOXICOLOGY, (1990), vol. 64, no. 1, pages 26 - 30, XP008007725 [X] 1,5-11 * abstract * DOI: http://dx.doi.org/10.1007/BF01973372 | [X] - TRIVEDI, B. K. ET AL., "Perfluoro-N-[4-(1,H-tertrazol-5-ylmethyl)phenyl]-alkanamides. A new class of oral antidiabetic agents", JOURNAL OF MEDICINAL CHEMISTRY, (1989), vol. 32, pages 11 - 13, XP001077053 [X] 1,5,6,8-11 * page 12, column 1, paragraph L * | [X] - OKOCHI E ET AL, "Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes", BIOCHIMICA AND BIOPHYSICA ACTA. MOLECULAR AND CELL BIOLOGY OFLIPIDS, ELSEVIER, AMSTERDAM, NL, (19990325), vol. 1437, no. 3, doi:10.1016/S1388-1981(99)00024-4, ISSN 1388-1981, pages 393 - 401, XP004277126 [X] 1,5-11 * abstract * DOI: http://dx.doi.org/10.1016/S1388-1981(99)00024-4 | [X] - SCHEDIN, S. ET AL., "Reduced cholesterol accumulation and improved deficient peroxisomal functions in a murine model of Niemann-Pick Type C Disease upon treatment with peroxisomal proliferators", BIOCHEMICAL PHARMACOLOGY, (1998), vol. 56, no. 9, pages 1195 - 1199, XP002212145 [X] 1,5-11 * abstract * DOI: http://dx.doi.org/10.1016/S0006-2952(98)00234-2 | by applicant | US2567011 | US4624851 | US6013795 | US6015838 | US6028109 | WO0107066 | - GILLILAND; MANDEL, J OCCUP MED, (1993), vol. 35, no. 9, pages 950 - 954 | - KEES, J MED CHEM, (1992), vol. 35, pages 944 - 953 | - KLIEWER, PNAS, (1994), vol. 91, pages 7355 - 7359 | - GELMAN, CELL MOL LIFE SCI, (1999), vol. 55, pages 932 - 943 | - KERSTEN, NATURE, (2000), vol. 405, pages 421 - 424 | - ISSEMANN; GREEN, NATURE, (1990), vol. 347, pages 645 - 650 | - AUBOEUF, DIABETES, (1997), vol. 46, no. 8, pages 1319 - 1327 | - BRAISSANT, ENDOCRINOL, (1996), vol. 137, no. 1, pages 354 - 366 | - MUKHERJEE, J STEROID BIOCHEM MOL BIOL, (1994), vol. 51, pages 157 - 166 | - MUKERJEE, J BIOL CHEM, (1997), vol. 272, pages 8071 - 8076 | - HLA, PROSTAGLANDINS, (1996), vol. 51, pages 81 - 85 | - HLA; NEILSON, PNAS, (1992), vol. 89, no. 16, pages 7384 - 7388 | - JONES, J BIOL CHEM, (1993), vol. 268, no. 12, pages 9049 - 9054 | - APPLEBY, BIOCHEM J, (1994), vol. 302, pages 723 - 727 | - KOSAKA, EUR J BIOCHEM, (1994), vol. 221, no. 3, pages 889 - 897 | - VALENTIN, BIOCHEM BIOPHYS RES COMMUN, (2000), vol. 279, no. 1, pages 223 - 228 | - BRASH, PNAS, (1997), vol. 94, no. 12, pages 6148 - 6152 | - UNDERWOOD, J BIOL CHEM, (1998), vol. 273, no. 34, pages 21926 - 21932 | - PICKARD, J BIOL CHEM, (1999), vol. 274, no. 13, pages 8823 - 8831 | - SHARP, J BIOL CHEM, (1991), vol. 266, no. 23, pages 14850 - 14853 | - PALMER, CAN; WOLF, CR., FEBS LETTS., (1998), vol. 431, pages 476 - 480 | - PALMER CAN; WOLF CR., FEBS LETTS., (1998), vol. 431, pages 476 - 480 | - CAUSEVIC M; WOLF CR; PALMER CAN., FEBS LETTS., (1999), vol. 463, pages 205 - 210 |